These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32888218)

  • 1. Cancer immunotherapy harnessing γδ T cells and programmed death-1.
    Tanaka Y
    Immunol Rev; 2020 Nov; 298(1):237-253. PubMed ID: 32888218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CAR-Modified Vγ9Vδ2 T Cells Propagated Using a Novel Bisphosphonate Prodrug for Allogeneic Adoptive Immunotherapy.
    Wang Y; Wang L; Seo N; Okumura S; Hayashi T; Akahori Y; Fujiwara H; Amaishi Y; Okamoto S; Mineno J; Tanaka Y; Kato T; Shiku H
    Int J Mol Sci; 2023 Jun; 24(13):. PubMed ID: 37446055
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug.
    Tanaka Y; Murata-Hirai K; Iwasaki M; Matsumoto K; Hayashi K; Kumagai A; Nada MH; Wang H; Kobayashi H; Kamitakahara H; Okamura H; Sugie T; Minato N; Toi M; Morita CT
    Cancer Sci; 2018 Mar; 109(3):587-599. PubMed ID: 29288540
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nano-technology based carriers for nitrogen-containing bisphosphonates delivery as sensitisers of γδ T cells for anticancer immunotherapy.
    Hodgins NO; Wang JT; Al-Jamal KT
    Adv Drug Deliv Rev; 2017 May; 114():143-160. PubMed ID: 28694026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Tumor Activity and Immunotherapeutic Potential of a Bisphosphonate Prodrug.
    Tanaka Y; Iwasaki M; Murata-Hirai K; Matsumoto K; Hayashi K; Okamura H; Sugie T; Minato N; Morita CT; Toi M
    Sci Rep; 2017 Jul; 7(1):5987. PubMed ID: 28729550
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-PD1 does not improve pyroptosis induced by γδ T cells but promotes tumor regression in a pleural mesothelioma mouse model.
    Lui KS; Ye Z; Chan HC; Tanaka Y; Cheung AKL
    Front Immunol; 2023; 14():1282710. PubMed ID: 38077396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cancer immunotherapy using gammadelta T cells ex vivo expanded by bisphosphonate].
    Kimura S
    Clin Calcium; 2008 Apr; 18(4):499-505. PubMed ID: 18379032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of a Novel Bisphosphonate Prodrug and Zoledronic Acid in the Induction of Cytotoxicity in Human Vγ2Vδ2 T Cells.
    Okuno D; Sugiura Y; Sakamoto N; Tagod MSO; Iwasaki M; Noda S; Tamura A; Senju H; Umeyama Y; Yamaguchi H; Suematsu M; Morita CT; Tanaka Y; Mukae H
    Front Immunol; 2020; 11():1405. PubMed ID: 32793196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three distinct mechanisms underlying human γδ T cell-mediated cytotoxicity against malignant pleural mesothelioma.
    Umeyama Y; Taniguchi H; Gyotoku H; Senju H; Tomono H; Takemoto S; Yamaguchi H; Tagod MSO; Iwasaki M; Tanaka Y; Mukae H
    Front Immunol; 2023; 14():1058838. PubMed ID: 37006249
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Zoledronate facilitates large-scale ex vivo expansion of functional gammadelta T cells from cancer patients for use in adoptive immunotherapy.
    Kondo M; Sakuta K; Noguchi A; Ariyoshi N; Sato K; Sato S; Sato K; Hosoi A; Nakajima J; Yoshida Y; Shiraishi K; Nakagawa K; Kakimi K
    Cytotherapy; 2008; 10(8):842-56. PubMed ID: 19016372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gamma-delta (γδ) T cells: friend or foe in cancer development?
    Zhao Y; Niu C; Cui J
    J Transl Med; 2018 Jan; 16(1):3. PubMed ID: 29316940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of gamma/delta T cells for solid tumor immunotherapy.
    Zhu D; Ren X; Xie W; Chen J; Liang S; Jiang M; Wang J; Zheng Z
    Front Immunol; 2024; 15():1466266. PubMed ID: 39253082
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the Effector Functions of Vδ2 γδ T Cells and NK Cells against Cholangiocarcinoma Cells.
    Kulma I; Na-Bangchang K; Carvallo Herrera A; Ndubuisi IT; Iwasaki M; Tomono H; Morita CT; Okamura H; Mukae H; Tanaka Y
    Cells; 2024 Aug; 13(16):. PubMed ID: 39195212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis of pyrophosphate-containing compounds that stimulate Vgamma2Vdelta2 T cells: application to cancer immunotherapy.
    Tanaka Y; Kobayashi H; Terasaki T; Toma H; Aruga A; Uchiyama T; Mizutani K; Mikami B; Morita CT; Minato N
    Med Chem; 2007 Jan; 3(1):85-99. PubMed ID: 17266628
    [TBL] [Abstract][Full Text] [Related]  

  • 15. γδ T cells in cancer immunotherapy.
    Zou C; Zhao P; Xiao Z; Han X; Fu F; Fu L
    Oncotarget; 2017 Jan; 8(5):8900-8909. PubMed ID: 27823972
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro potency, in vitro and in vivo efficacy of liposomal alendronate in combination with γδ T cell immunotherapy in mice.
    Hodgins NO; Al-Jamal WT; Wang JT; Parente-Pereira AC; Liu M; Maher J; Al-Jamal KT
    J Control Release; 2016 Nov; 241():229-241. PubMed ID: 27664328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Zoledronate-activated Vγ9γδ T cell-based immunotherapy is feasible and restores the impairment of γδ T cells in patients with solid tumors.
    Noguchi A; Kaneko T; Kamigaki T; Fujimoto K; Ozawa M; Saito M; Ariyoshi N; Goto S
    Cytotherapy; 2011 Jan; 13(1):92-7. PubMed ID: 20831354
    [TBL] [Abstract][Full Text] [Related]  

  • 18. γδ T-cell immunotherapy for lung cancer.
    Yoshida Y; Nakajima J; Wada H; Kakimi K
    Surg Today; 2011 May; 41(5):606-11. PubMed ID: 21533930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strategies to Improve the Antitumor Effect of γδ T Cell Immunotherapy for Clinical Application.
    Miyashita M; Shimizu T; Ashihara E; Ukimura O
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antitumor activity and some immunological properties of gammadelta T-cells from patients with gastrointestinal carcinomas.
    Murayama M; Tanaka Y; Yagi J; Uchiyama T; Ogawa K
    Anticancer Res; 2008; 28(5B):2921-31. PubMed ID: 19031935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.